These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19755825)

  • 1. [A case of stage IV breast cancer with large cancer ulcer responding to combination therapy of capecitabine and medroxyprogesterone acetate and cyclophosphamide].
    Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1525-8. PubMed ID: 19755825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of recurrent breast cancer with multiple liver metastases responding to combination therapy of capecitabine and MPA].
    Konishi K; Hasegawa N; Kawabata M; Abeshima S; Ichimura T; Kaneko H; Nakayama T
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1689-91. PubMed ID: 17940392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral combination chemotherapy with capecitabine and cyclophosphamide in combination with endocrine therapy and anti-HER2 therapy for advanced and metastatic breast cancer].
    Okamura R; Kato T; Sata R
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():592-6. PubMed ID: 23350469
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of elderly metastatic breast cancer with a complete response to treatment with capecitabine and cyclophosphamide].
    Iida S; Furukawa K; Yokoyama T; Yanagihara K; Iwasaki R; Noguchi T; Tsuchiya S; Sugisaki Y; Naito Z; Tajiri T
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1697-700. PubMed ID: 17940394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of metastatic breast cancer with bilateral hydronephrosis effectively treated with capecitabine].
    Yamauchi S; Nakagawa T; Kasahara M; Sugimoto H; Ishiba T; Tamura N; Nagahara M; Sato T; Sugihara K
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2077-9. PubMed ID: 23267982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two cases of HER2-positive advanced or metastatic breast cancer, responding to lapatinib and capecitabine].
    Nakamura Y; Aono T; Nomura M; Iwase K; Tanaka Y
    Gan To Kagaku Ryoho; 2010 Nov; 37(11):2165-8. PubMed ID: 21084819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of HER2 overexpressing advanced breast cancer with CTF therapy [cyclophosphamide, pirarubicin (THPADM), fluorouracil] showed long-term effectiveness after paclitaxel shock].
    Ikeda M; Sonoo H; Oota Y; Fujii S; Shimo T; Miyake A; Seki M; Nomura T; Yamamoto Y; Shiiki S; Nakashima K; Tanaka K; Kurebayashi J
    Gan To Kagaku Ryoho; 2010 Dec; 37(13):2917-20. PubMed ID: 21160270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study.
    von Minckwitz G; Rezai M; Loibl S; Fasching PA; Huober J; Tesch H; Bauerfeind I; Hilfrich J; Eidtmann H; Gerber B; Hanusch C; Kühn T; du Bois A; Blohmer JU; Thomssen C; Dan Costa S; Jackisch C; Kaufmann M; Mehta K; Untch M
    J Clin Oncol; 2010 Apr; 28(12):2015-23. PubMed ID: 20308671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful combination therapy with 5'-DFUR and MPA for breast cancer with spinal and vertebral metastases].
    Otani S; Toyota N; Nozaka K; Wakatsuki T; Takebayashi M; Kamasako A; Tanida O; Hashiguchi H; Ohgami Y; Hirooka Y
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2151-3. PubMed ID: 15628761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study.
    Untch M; Rezai M; Loibl S; Fasching PA; Huober J; Tesch H; Bauerfeind I; Hilfrich J; Eidtmann H; Gerber B; Hanusch C; Kühn T; du Bois A; Blohmer JU; Thomssen C; Dan Costa S; Jackisch C; Kaufmann M; Mehta K; von Minckwitz G
    J Clin Oncol; 2010 Apr; 28(12):2024-31. PubMed ID: 20308670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
    Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
    J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel followed by fluorouracil/epirubicin/cyclophosphamide as neoadjuvant chemotherapy for patients with primary breast cancer.
    Iwata H; Sato N; Masuda N; Nakamura S; Yamamoto N; Kuroi K; Kurosumi M; Tsuda H; Akiyama F; Ohashi Y; Toi M
    Jpn J Clin Oncol; 2011 Jul; 41(7):867-75. PubMed ID: 21719750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
    Yokota T; Fujii T; Roppongi T; Kanno K; Ogata T
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):739-42. PubMed ID: 9571973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report].
    Fukuda Y; Hirao S; Koyama I; Takatori H; Terakura M; Mayumi K; Tsukazaki Y; Kinoshita H
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):217-20. PubMed ID: 11242649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
    J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer.
    Yoshimoto M; Takao S; Hirata M; Okamoto Y; Yamashita S; Kawaguchi Y; Takami M; Furusawa H; Morita S; Abe C; Sakamoto J
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):331-8. PubMed ID: 22526409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of FEC and trastuzumab/docetaxel combination therapy for metastatic breast cancer].
    Matsumoto K; Yoshinouchi S; Takano Y; Kanzaki M; Maeda M; Miyoshi S; Wakita T; Teshima S
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):503-5. PubMed ID: 20332692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of premenopausal stage IV breast cancer responding to neoadjuvant endocrine therapy after chemotherapy with FEC].
    Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):111-3. PubMed ID: 20087042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of breast cancer with multiple organ metastases responding remarkably to combination therapy of CAF (cyclophosphamide, adriamycin and 5-FU), 5'-DFUR and MPA (medroxyprogesterone acetate)].
    Maruyama S; Okumoto T; Kawasaki K; Ino H; Kanaya Y; Otani J; Yokoyama N; Soda M
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2235-8. PubMed ID: 11142168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of bilateral breast cancer and metastatic gastric cancer with peritonitis carcinomatosa successfully treated with a combination therapy of S-1 and paclitaxel].
    Ueno S; Nakakuma T; Aramaki N; Shiozawa K; Iizuka M; Kurita A; Miyauchi K; Sengoku N; Kuranami M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2471-3. PubMed ID: 20037459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.